Researchers at Emory University in Atlanta will lead the effort — known as project “CureIt” — using $24 million in new funding from the Advanced Research Projects Agency for Health.
CureIt’s primary goal is to “create a toolbox of mRNA and related technologies that could be used to “turn on” helpful immune responses, like prompting immune cells to target and attack tumors…” the release states. “A toolbox of mRNA platforms offers the potential to transform the fight against cancer and other difficult diseases.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
